Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment

PURPOSE: To investigate the effectiveness of mineralocorticoid receptor (MR) antagonist in patients with steroid-induced central serous chorioretinopathy (CSC). METHODS: A retrospective review was conducted of steroid-induced CSC patients who were treated with the MR antagonist spironolactone 50 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Young, Chae, Ju Byung, Kim, Jisoo, Kim, Dong Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081588/
https://www.ncbi.nlm.nih.gov/pubmed/30140452
http://dx.doi.org/10.1155/2018/4258763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081588/
https://www.ncbi.nlm.nih.gov/pubmed/30140452
http://dx.doi.org/10.1155/2018/4258763

Ejemplares similares